Green Eric Mark's Insider Trades & SAST Disclosures
Green Eric Mark's most recent trade in West Pharmaceutical Services, Inc. was a trade of 12,149 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Green Eric Mark.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 12,149 | 12,149 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 5,256 | 5,256 | - | - | Rst. Stock Unit | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 211.08 per share. | 18 Feb 2025 | 2,460 | 170,369 (0%) | 0% | 211.1 | 519,269 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 211.09 per share. | 18 Feb 2025 | 700 | 169,668 (0%) | 0% | 211.1 | 147,762 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 30,732 | 6,000 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 304.71 per share. | 06 Aug 2024 | 30,732 | 161,898 (0%) | 0% | 304.7 | 9,364,409 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 06 Aug 2024 | 30,732 | 192,640 (0%) | 0% | 59.6 | 1,832,856 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 6,000 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 06 Aug 2024 | 6,000 | 167,898 (0%) | 0% | 59.6 | 357,840 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 41,000 | 45,732 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 366.65 per share. | 07 May 2024 | 41,000 | 152,908 (0%) | 0% | 366.7 | 15,032,736 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 07 May 2024 | 41,000 | 218,908 (0%) | 0% | 59.6 | 2,445,240 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 366.65 per share. | 07 May 2024 | 41,000 | 152,908 (0%) | 0% | 366.7 | 15,032,736 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 07 May 2024 | 41,000 | 218,908 (0%) | 0% | 59.6 | 2,445,240 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 41,000 | 45,732 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 15,684 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 366.66 per share. | 07 May 2024 | 15,684 | 193,908 (0%) | 0% | 366.7 | 5,750,678 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 07 May 2024 | 15,684 | 177,908 (0%) | 0% | 57.4 | 899,948 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 366.66 per share. | 07 May 2024 | 15,684 | 193,908 (0%) | 0% | 366.7 | 5,750,678 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 07 May 2024 | 15,684 | 177,908 (0%) | 0% | 57.4 | 899,948 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 15,684 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 07 May 2024 | 9,316 | 162,224 (0%) | 0% | 57.4 | 534,552 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 9,316 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 366.64 per share. | 07 May 2024 | 9,316 | 209,952 (0%) | 0% | 366.6 | 3,415,636 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 366.64 per share. | 07 May 2024 | 9,316 | 209,952 (0%) | 0% | 366.6 | 3,415,636 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 07 May 2024 | 9,316 | 162,224 (0%) | 0% | 57.4 | 534,552 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 9,316 | 0 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 9,000 | 36,732 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 07 May 2024 | 9,000 | 161,908 (0%) | 0% | 59.6 | 536,760 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 9,000 | 36,732 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.64 per share. | 07 May 2024 | 9,000 | 161,908 (0%) | 0% | 59.6 | 536,760 | Common Stock |
| West Pharmaceutical Servic... | Mark Green Eric | Director, President, CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 359.85 per share. | 27 Feb 2024 | 64,132 | 152,908 (0%) | 0% | 359.9 | 23,077,971 | Common Stock |
| West Pharmaceutical Servic... | Mark Eric Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 64,132 | 15,684 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Green Mark | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 27 Feb 2024 | 64,132 | 217,040 (0%) | 0% | 57.4 | 3,679,894 | Common Stock |
| West Pharmaceutical Servic... | Green Mark Eric | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 27 Feb 2024 | 9,000 | 152,908 (0%) | 0% | 57.4 | 516,420 | Common Stock |
| West Pharmaceutical Servic... | Mark Eric Green | Director, President, CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 9,000 | 9,316 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Mark Green Eric | Director, President, CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 25,221 | 25,221 | - | - | Stock Options (Right to Buy) | |
| West Pharmaceutical Servic... | Green Eric Mark | Director, President, CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 6,567 | 148,202 (0%) | 0% | 0 | Common Stock | |
| West Pharmaceutical Servic... | Mark Eric Green | Director, President, CEO and Board Chair | Gift of securities by or to the insider at price $ 343.00 per share. | 06 Dec 2023 | 9,800 | 130,774 (0%) | 0% | 343 | 3,361,400 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 08 Aug 2023 | 50,000 | 184,574 (0%) | 0% | 57.4 | 2,869,000 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 50,000 | 98,132 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 394.17 per share. | 08 Aug 2023 | 8,329 | 163,690 (0%) | 0% | 394.2 | 3,283,075 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 395.07 per share. | 08 Aug 2023 | 7,684 | 156,006 (0%) | 0% | 395.1 | 3,035,743 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 397.18 per share. | 08 Aug 2023 | 7,532 | 141,774 (0%) | 0% | 397.2 | 2,991,531 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 393.13 per share. | 08 Aug 2023 | 7,055 | 172,019 (0%) | 0% | 393.1 | 2,773,539 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 396.13 per share. | 08 Aug 2023 | 6,700 | 149,306 (0%) | 0% | 396.1 | 2,654,040 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 392.16 per share. | 08 Aug 2023 | 4,500 | 179,074 (0%) | 0% | 392.2 | 1,764,699 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 397.90 per share. | 08 Aug 2023 | 1,100 | 140,674 (0%) | 0% | 397.9 | 437,686 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 389.62 per share. | 08 Aug 2023 | 1,000 | 183,574 (0%) | 0% | 389.6 | 389,620 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 398.87 per share. | 08 Aug 2023 | 100 | 140,574 (0%) | 0% | 398.9 | 39,887 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 09 May 2023 | 50,000 | 178,574 (0%) | 0% | 57.4 | 2,869,000 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 50,000 | 148,132 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 361.95 per share. | 09 May 2023 | 14,157 | 164,417 (0%) | 0% | 361.9 | 5,124,081 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 363.94 per share. | 09 May 2023 | 12,648 | 139,207 (0%) | 0% | 363.9 | 4,603,055 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 362.93 per share. | 09 May 2023 | 12,562 | 151,855 (0%) | 0% | 362.9 | 4,559,085 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 364.76 per share. | 09 May 2023 | 4,133 | 135,074 (0%) | 0% | 364.8 | 1,507,572 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 365.46 per share. | 09 May 2023 | 500 | 134,574 (0%) | 0% | 365.5 | 182,729 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2023 | 50,000 | 198,132 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 07 Mar 2023 | 50,000 | 135,705 (0%) | 0% | 57.4 | 2,869,000 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 322.49 per share. | 07 Mar 2023 | 26,753 | 96,544 (0%) | 0% | 322.5 | 8,627,505 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 321.61 per share. | 07 Mar 2023 | 7,685 | 88,859 (0%) | 0% | 321.6 | 2,471,602 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 323.38 per share. | 07 Mar 2023 | 5,277 | 123,297 (0%) | 0% | 323.4 | 1,706,478 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 320.60 per share. | 07 Mar 2023 | 3,154 | 85,705 (0%) | 0% | 320.6 | 1,011,173 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 324.29 per share. | 07 Mar 2023 | 1,131 | 128,574 (0%) | 0% | 324.3 | 366,772 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 29,872 | 29,872 | - | - | Stock Options (Right to buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 306.68 per share. | 21 Feb 2023 | 14,783 | 129,705 (0%) | 0% | 306.7 | 4,533,650 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Gift of securities by or to the insider at price $ 371.47 per share. | 31 Dec 2022 | 2,700 | 125,874 (0%) | 0% | 371.5 | 1,002,969 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.38 per share. | 05 Dec 2022 | 50,000 | 158,922 (0%) | 0% | 57.4 | 2,869,000 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2022 | 50,000 | 248,132 | - | - | Stock Option (Right to Buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 239.70 per share. | 05 Dec 2022 | 10,752 | 125,704 (0%) | 0% | 239.7 | 2,577,224 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 240.73 per share. | 05 Dec 2022 | 9,682 | 116,022 (0%) | 0% | 240.7 | 2,330,775 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 237.67 per share. | 05 Dec 2022 | 9,408 | 142,768 (0%) | 0% | 237.7 | 2,235,977 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 236.95 per share. | 05 Dec 2022 | 6,746 | 152,176 (0%) | 0% | 236.9 | 1,598,457 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 238.83 per share. | 05 Dec 2022 | 6,312 | 136,456 (0%) | 0% | 238.8 | 1,507,475 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 241.46 per share. | 05 Dec 2022 | 1,100 | 114,922 (0%) | 0% | 241.5 | 265,611 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 31,088 | 31,088 | - | - | Stock Options (Right to buy) | |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 369.13 per share. | 22 Feb 2022 | 22,104 | 108,922 (0%) | 0% | 369.1 | 8,159,250 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 391.20 per share. | 13 Feb 2022 | 85 | 86,818 (0%) | 0% | 391.2 | 33,252 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 272.65 per share. | 22 Feb 2021 | 17,767 | 90,053 (0%) | 0% | 272.7 | 4,844,173 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.01 per share. | 14 Feb 2021 | 92 | 72,286 (0%) | 0% | 294.0 | 27,049 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.00 per share. | 03 Jun 2020 | 5 | 72,378 (0%) | 0% | 198 | 990 | Common Stock |
| West Pharmaceutical Servic... | Eric Mark Green | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.54 per share. | 24 Apr 2020 | 5,858 | 72,373 (0%) | 0% | 195.5 | 1,145,473 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges